AzTrials
AzTrials

EmpathyNCT05736276

Empathy Levels Among Undergraduate Medical Students in Karachi, Pakistan - a Cross-sectional Study

An observational study of Empathy, run by Ziauddin University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Empathy is a concept native to the field of medicine. However, over the course of medical school, empathy levels are expected to decline. The aim of this study was to assess the empathy levels amongst medical students in relation to their year of study and specialties of choice in the future. Read more about this study

Who is it for?
Ages 17 to 24 yearsHealthy volunteers can take part
Conditions the study is for
Empathy
How many people
463 participants
Where
1 sitePakistan
Study dates
1 Jun 2022to 30 Jul 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 24 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Undergraduate medical students enrolled in different years of the academic program were involved to cater to those in the pre-clinical years as well as those receiving clinical exposure.

Who may be able to join

  • undergraduate medical students

Who cannot join

  • all the remaining population

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Ziauddin University

    Karachi, Sindh, 75600

Other trials in Pakistan

About this study

Empathy is a concept native to the field of medicine. However, over the course of medical school, empathy levels are expected to decline. The aim of this study was to assess the empathy levels amongst medical students in relation to their year of study and specialties of choice in the future. A cross-sectional study was conducted to assess empathy levels among students from medical colleges in Karachi, Pakistan, using an online survey. The total duration of the study was two months. The authors analyzed the data using SPSS version 20. A total of 463 undergraduate medical students participated in this survey.

Conditions
Empathy
Keywords
empathy, medical students, Pakistan, surveys and questionnaires, observational study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Empathy score on the Jefferson Scale of Empathy (JSE)

    The total score range of the JSE is 20-140. Each factor of the questionnaire attributes to both positive and negatively phrased questions with '1' signifying 'strongly disagree' and '7' signifying 'strongly agree'.

    Measured: June 2022 - July 2022

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2023
  2. Study start1 Jun 2022
  3. Primary completion30 Jul 2022
  4. Study completion30 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
463 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05736276
Sponsor's protocol ID
0110721MNY5
Status last verified
Jan 2023
First submitted
18 Jan 2023
Last updated
21 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Empathy, run by Ziauddin University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Empathy score on the Jefferson Scale of Empathy (JSE) (time frame: June 2022 - July 2022). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in